Thrombectomy Devices Market Size & Share 2023 to 2032
Market Size by Product Type (Ultrasound-assisted Thrombectomy Devices, Rotational Thrombectomy Devices, Aspiration Thrombectomy Devices, Mechanical/Fragmentation Thrombectomy Devices, Clot Extraction Catheter, Stent Retrievers, Microcatheters), by Application, by End Use – Global Forecast.
Report ID: GMI5245
|
Published Date: September 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Pratiksha Kamthe
Thrombectomy Devices Market Size
Thrombectomy Devices Market size was worth USD 1.4 billion in 2022 and is estimated to expand significantly at 7.3% CAGR from 2023 to 2032, driven by the increasing prevalence of cardiovascular disorders and the surging need for effective treatment procedures worldwide.
Thrombectomy Devices Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
The increasing burden of sedentary lifestyles in both developed and developing countries is dramatically increasing the frequency of cardiovascular diseases, propelling the demand for thrombectomy operations. The rising instances of disease-related mortality is further driving the need for efficient treatment methods. For instance, the WHO estimates that cardiovascular disease causes more than 17 million deaths yearly, or around 31% of all fatalities worldwide. Patients with such long-term cardiac issues may have platelet aggregation or clotting, thus, raising the possibility of abrupt heart failure or heart attack, subsequently driving the industry landscape.
The rising exposure to various regulations and guidelines established by regulating authorities may impede the thrombectomy devices market progress. While regulations are vital for patient safety and product quality, the presence of overly complex and stringent frameworks is leading to restrained innovation. The lengthy approval processes and rigorous compliance requirements is also making way for delays in product launches, increasing development costs, and limited market access for new entrants. However, the rising efforts towards streamlining the regulatory processes and promoting clearer communication along with the continued advancements in thrombectomy device technologies will assist in the market growth.
COVID-19 Impact
The COVID-19 pandemic positively impacted the market expansion despite the disruption to various healthcare operations driven by the rising need for operations to match the greater risk of thromboembolism among the infected patients. Furthermore, the substantial death rate was brought on by the rising proportion of COVID-19 patients who suffered acute ischemic strokes. The American Heart Association reported that acute ischemic strokes (AIS) occurred in about 1.3% of COVID-19-infected people. Thus, the increased requirement for efficient treatment procedures boosted the product demand in the pandemic.
Thrombectomy Devices Market Trends
Surging technological advancements in thrombectomy devices will strengthen the industry growth potential during 2023-2032. The introduction of innovative devices is offering higher efficiency and ease in the clinical workflow to physicians performing thrombectomy procedures. Furthermore, growing advancements in thrombectomy devices to provide maximum precision in minimally invasive procedures will add to the product adoption rate. In September 2021, Abbott announced the acquisition of Walk Vascular, LLC, a mechanical aspiration thrombectomy system developer for the removal of peripheral blood clots. The acquisition extended Abbott's vascular device portfolio and its capacity to provide unique endovascular treatment options to improve patient care.
Thrombectomy Devices Market Analysis
Thrombectomy devices market from mechanical/fragmentation segment size is estimated to record USD 840 million by 2032 owing to expanding usage to offer improved efficacy in the treatment of diseases. Moreover, the rise in R&D investments by industry players for introducing highly advanced mechanical thrombectomy devices integrated with advanced computer-aided components will add to the segment progress. To cite an instance, in January 2023, Penumbra, Inc. announced the approval and launch of Lightning FlashTM, the most advanced and powerful mechanical thrombectomy system featuring an advanced microprocessor algorithm.
Thrombectomy devices market from the cardiovascular thrombectomy application segment is likely to witness around 7.3% CAGR from 2023 to 2032. The growth is attributed to the surge in the number of patients suffering from severe heart conditions. According to research published in the Journal of the American College of Cardiology in August 2022, the estimated rate of cardiovascular risk factors and disease in the U.S. would rise considerably by 2060. Significant increases in cardiovascular trends may add to the burden on the American healthcare system and highlight the need for fair access to early disease preventive education and treatment options, subsequently surging the need for cardiovascular thrombectomy.
North America thrombectomy devices market size is expected to expand at 7.4% CAGR from 2023-2032 driven by the growing awareness regarding vascular diseases, increasing healthcare expenditure, favorable reimbursement scenarios, and government initiatives. The rapidly expanding geriatric population base highly prone to several chronic disorders along with the increasing preference for non-surgical treatments has pushed several manufacturers to introduce medically advanced devices, leading to enhanced regional industry growth. For instance, in June 2023, Surmodics, Inc., announced that it had received the U.S. FDA 510(k) clearance for its Pounce™ LP Thrombectomy System designed for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature.
Thrombectomy Devices Market Share
The competitive landscape of the thrombectomy devices market includes prominent companies, such as
Thrombectomy Devices Market News
Thrombectomy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product Type (USD Million)
By Application (USD Million)
By End-use (USD Million)
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →